These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 658004)

  • 1. [Effect of adepren on the cerebral concentration of serotonin].
    Tiutiulkova N; Gorancheva Iu
    Eksp Med Morfol; 1978; 17(2):83-5. PubMed ID: 658004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of adepren on the rate of cerebral noradrenaline metabolism].
    Tiutiulkova N; Gorancheva Iu
    Eksp Med Morfol; 1978; 17(2):80-3. PubMed ID: 658003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of adepren on the behavior and brain catecholamines of rats in an open field setup].
    Stefanova D; Tiutiulkova N; Nikolova M
    Eksp Med Morfol; 1976; 15(1):42-6. PubMed ID: 1269462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):65-83. PubMed ID: 4775865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of the inhibition of monoamine oxidase on daily oscillation of the serotonin content of the brain].
    Montanaro N; Casoli R; Babbini M
    Arch Ital Sci Farmacol; 1965; 15(1):84-6. PubMed ID: 5871028
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
    Blier P; De Montigny C; Azzaro AJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):207-21. PubMed ID: 7244360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetic analysis of the Bulgarian preparation Adepren in experimental animals].
    Michajlova D; Nakova G; Nacev I
    Cesk Farm; 1981 Sep; 30(7):226-9. PubMed ID: 7307083
    [No Abstract]   [Full Text] [Related]  

  • 12. Adepren influence in acetylcholinesterase and monoamineoxidase activity: biochemical and histochemical study.
    Tyutyulkova N; Markova St; Sheikov N
    Act Nerv Super (Praha); 1976; 18(3):200-2. PubMed ID: 1007855
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of a new oxazolidinone derivative AS-8 on serotonin metabolism in the brains of mouse, rat and chick.
    Chilmonczyk Z
    Pol J Pharmacol; 1995; 47(5):445-9. PubMed ID: 8868138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resorption, distribution and excretion of the Bulgarian preparation, adepren, in experimental animals].
    Nakova G; Ognianova V
    Eksp Med Morfol; 1979; 18(1):12-7. PubMed ID: 436706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Excretion of dopamine, noradrenaline, adrenaline, vanilmandelic acid and 5-hydroxyindoleacetic acid in the urine of volunteers treated with adepren].
    Tiutiulkova NI; Gorancheva IuI
    Eksp Med Morfol; 1975; 14(4):187-9. PubMed ID: 1222713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase by viloxazine in rats.
    Martinez C; Dominiak P; Kees F; Grobecker H
    Arzneimittelforschung; 1986 May; 36(5):800-3. PubMed ID: 2425816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical pharmacology of the central nervous system. 6. Specific inhibitors of enzymes implied in the synthesis of cerebral serotonin].
    Corgier M; Pacheco H
    Therapie; 1973; 28(4):639-49. PubMed ID: 4793684
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigations on the relations between the biochemical changes in the brain and behaviour of irradiated rats.
    Koćmierska-Grodzka D; Romatowska A; Szymański A
    Strahlentherapie; 1975 Jul; 150(1):102-8. PubMed ID: 1166469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of isatin on certain enzymes, lipids & serotonergic system of rat brain.
    Kumar R; Bansal RC; Mahmood A
    Indian J Med Res; 1994 Nov; 100():246-50. PubMed ID: 7829161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.